IPR Amicus: October 2017

US Food and Drug Administration (FDA) and Oncologic Drugs Advisory Committee (ODAC) have unanimously approved CTL019 (tisagenlecleucel) or Kymriah®, an investigational chimeric antigen receptor T cell (CAR-T) therapy.

IPR Amicus: September2017

IP law provides means by which the IP rights may be effectively enforced against infringement. However, the law also has provisions to prevent any person, especially right-owners, from making indiscriminate threats of infringement proceedings against others.

IPR Amicus: August 2017

Recently the Indian Patent Office refused to grant a patent to the Regents of University of California, for Enzalutamide on the ground that the invention lacked inventive step and was not patent eligible under Sections 3(d) and 3(e) of the Indian Patents Act.

IPR Amicus: July 2017

The Patent Office has released another revised version of guidelines for examination of Computer Related Inventions (CRIs).

IPR Amicus: June 2017

One of the defences available to a defendant in a patent infringement suit for avoiding damages, is that he/she was unaware of the existence of the patent(s) alleged to be infringed.

IPR Amicus: April 2017

Indian Courts have predominantly applied the test, termed as the ‘Classical Trinity factors’ as set out in the landmark House of Lords decision in Reckitt & Colman Products Ltd v Borden Inc.

IPR Amicus: May 2017

High Court of Delhi has opined that the drawing cannot simpliciter be termed as a mechanical device to get the benefit of being excluded from Section 2(d) of the Designs Act.

IPR Amicus: March 2017

Article in this issue of IPR Amicus discusses a recent decision of the Delhi High Court involving liability of an intermediary in a design infringement case.

IPR Amicus: February 2017

Article in this issue of IPR Amicus discusses a recent decision of the Delhi High Court granting permanent injunction in a dispute involving use of mark similar to that of Mother Dairy.

IPR Amicus: January 2017

Trans-border reputation as the name suggests means reputation that has spilled over to other jurisdictions wherein there is neither use of the trade mark in question nor is the trade mark registered.